BioCentury | Dec 8, 2014
Company News

PneumRx, BTG deal

...BTG will acquire pulmonary device maker PneumRx for €186 million ($230 million) up front and up...
...million ($230 million) up front and up to €199 million ($246 million) in performance-related milestones. PneumRx...
...has completed enrollment in a U.S. pivotal trial, where the company expects approval in 2016. PneumRx...
BioCentury | Dec 5, 2014
Financial News

BTG raises L150M, acquires PneumRx

...Asset Management purchased 3.3 million shares worth L25.9 million. BTG also acquired pulmonary device maker PneumRx Inc....
...Mountain View, Calif.) for $230 million up front and up to $245 million in milestones. PneumRx...
Items per page:
1 - 2 of 2
BioCentury | Dec 8, 2014
Company News

PneumRx, BTG deal

...BTG will acquire pulmonary device maker PneumRx for €186 million ($230 million) up front and up...
...million ($230 million) up front and up to €199 million ($246 million) in performance-related milestones. PneumRx...
...has completed enrollment in a U.S. pivotal trial, where the company expects approval in 2016. PneumRx...
BioCentury | Dec 5, 2014
Financial News

BTG raises L150M, acquires PneumRx

...Asset Management purchased 3.3 million shares worth L25.9 million. BTG also acquired pulmonary device maker PneumRx Inc....
...Mountain View, Calif.) for $230 million up front and up to $245 million in milestones. PneumRx...
Items per page:
1 - 2 of 2